MedPath

LABORATOIRES TERIAK

🇹🇳Tunisia
Ownership
-
Employees
-
Market Cap
-
Website

Incidence of Major Cardiovascular Events in Diabetic Patients With ACS Undergoing Coronary Angioplasty and Treated With Clopidogrel 150 mg Versus 75 mg

Phase 4
Completed
Conditions
Diabetes Mellitus, Type 2
NSTEMI - Non-ST Segment Elevation MI
Coronary Angioplasty
Interventions
First Posted Date
2017-11-01
Last Posted Date
2019-12-23
Lead Sponsor
Laboratoires Teriak
Target Recruit Count
167
Registration Number
NCT03329261
Locations
🇹🇳

HMPIT, Ben Arous, Tunisia

© Copyright 2025. All Rights Reserved by MedPath